The PGA Tour names Cologuard as official colon cancer screening sponsor
March 2, 2018
The PGA Tour has named Cologuard, a noninvasive at-home colon cancer screening test manufactured by Exact Sciences as the official colon cancer screening sponsor.
The partnership includes global rights through 2020. As part of the company’s marketing partnership with the PGA Tour, players, tournaments, title sponsors, fans and Tour staff will be challenged to take part in a season-long pledge program to get screened for colon cancer.
Through Cologuard, the company will create an onsite presence at a number of PGA Tour Champions events to encourage screening for average risk adults age 50 and over and to raise awareness about colon cancer.
“We are excited to announce Cologuard as a new marketing partner of both the PGA Tour and PGA Tour Champions,” said PGA Tour Champions president Greg McLaughlin.
“Colon cancer awareness is an important societal discussion, and one our players will look to further with this relationship. Today’s announcement allows the Tour to create a more concrete foundation from which to develop those efforts.”
“The PGA Tour is a tremendous supporter of our efforts to help raise awareness about the most preventable yet least prevented cancer,” said Kevin Conroy, chairman and CEO of Exact Sciences.
“It is an honor to become the official colon cancer screening sponsor of the PGA Tour and PGA Tour Champions. More than one in three Americans are not current with their colon cancer screening. With the help of Cologuard, ambassador Jerry Kelly, and the PGA Tour, we are committed to ensuring more people get screened.”
